These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Locally administered ocular corticosteroids: benefits and risks. McGhee CN; Dean S; Danesh-Meyer H Drug Saf; 2002; 25(1):33-55. PubMed ID: 11820911 [TBL] [Abstract][Full Text] [Related]
25. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Ozerdem U; Levi L; Cheng L; Song MK; Scher C; Freeman WR Am J Ophthalmol; 2000 Aug; 130(2):240-1. PubMed ID: 11004305 [TBL] [Abstract][Full Text] [Related]
29. [Ophthalmological applications of hydrocortisone ointment]. Polos'iants OB Klin Med (Mosk); 1999; 77(11):40-1. PubMed ID: 10635632 [TBL] [Abstract][Full Text] [Related]
30. Ocular effects of topical and systemic corticosteroids. David DS; Berkowitz JS Lancet; 1969 Jul; 2(7612):149-51. PubMed ID: 4183257 [No Abstract] [Full Text] [Related]
31. Dermatologic use of glucocorticoids. Systemic and topical. Scott DW Vet Clin North Am Small Anim Pract; 1982 Feb; 12(1):19-32. PubMed ID: 7048711 [TBL] [Abstract][Full Text] [Related]
33. [Hormonal anti-inflammatory and anti-allergic ocular drugs and their use (review of the literature)]. Inkeniene AM; Klimas R Medicina (Kaunas); 2002; 38(8):779-84. PubMed ID: 12474747 [TBL] [Abstract][Full Text] [Related]
34. When to use topical steroids in the treatment of eye disease. Jeffers FB Occup Health Nurs; 1981 Jun; 29(6):31, 45. PubMed ID: 6909668 [No Abstract] [Full Text] [Related]
35. A comprehensive review of the adverse effects of systemic corticosteroids. Poetker DM; Reh DD Otolaryngol Clin North Am; 2010 Aug; 43(4):753-68. PubMed ID: 20599080 [TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of clobetasone butyrate: a comparative study of its effects in postoperative inflammation and on intraocular pressure. Ramsell TG; Bartholomew RS; Walker SR Br J Ophthalmol; 1980 Jan; 64(1):43-5. PubMed ID: 6986899 [TBL] [Abstract][Full Text] [Related]
37. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Rechtman E; Allen VD; Danis RP; Pratt LM; Harris A; Speicher MA Am J Ophthalmol; 2003 Oct; 136(4):739-41. PubMed ID: 14516819 [TBL] [Abstract][Full Text] [Related]
38. The safety profile of long-term, high-dose intraocular corticosteroid delivery. Holekamp NM; Thomas MA; Pearson A Am J Ophthalmol; 2005 Mar; 139(3):421-8. PubMed ID: 15767049 [TBL] [Abstract][Full Text] [Related]
39. Corticosteroid therapy of eye disease. Fifty years later. Raizman M Arch Ophthalmol; 1996 Aug; 114(8):1000-1. PubMed ID: 8694704 [No Abstract] [Full Text] [Related]
40. Steroid therapy in ophthalmology. Kochman MC; Kochman RC N Y State J Med; 1973 Sep; 73(17):2140-3. PubMed ID: 4517012 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]